Albumedix has a total of 203 patents globally, out of which 105 have been granted. Of these 203 patents, more than 60% patents are active. United States of America is where Albumedix has filed the maximum number of patents, followed by Europe and Japan. Parallelly, Europe seems to be the main focused R&D centre and also United Kingdom is the origin country of Albumedix.
Albumedix was founded in the year 2015. The Company manufactures recombinant proteins from yeast for use in bio manufacturing, drug delivery and medical devices. The Company’s products include recombinant albumin, expression platforms, hyaluronic acid, and purification ligands.
Do read about some of the most popular patents of Albumedix which have been covered by us in this article and also you can find Albumedix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Albumedix patent portfolio.
How many patents does the CEO of Albumedix have?
The CEO Jonas S. Moller has 0 patent.
How many patents does Albumedix have?
Albumedix has a total of 203 patents globally. These patents belong to 53 unique patent families. Out of 203 patents, 123 patents are active.
How Many Patents did Albumedix File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Albumedix Applications Filed | Albumedix Patents Granted |
| 2023 | – | 6 |
| 2022 | 2 | 11 |
| 2021 | 3 | 5 |
| 2020 | 7 | 8 |
| 2019 | 11 | 17 |
| 2018 | 25 | 16 |
| 2017 | 26 | 20 |
| 2016 | 21 | 4 |
| 2015 | 16 | 6 |
| 2014 | 15 | 2 |
| 2013 | 18 | – |
| 2012 | 19 | 2 |
How many Albumedix patents are Alive/Dead?
How Many Patents did Albumedix File in Different Countries?
Countries in which Albumedix Filed Patents
| Country | Patents |
| United States Of America | 70 |
| Europe | 20 |
| Japan | 18 |
| Australia | 16 |
| India | 11 |
| Denmark | 8 |
| China | 8 |
| Spain | 7 |
| Israel | 6 |
| Mexico | 5 |
| Korea (South) | 5 |
| Canada | 4 |
| Brazil | 4 |
| Hong Kong (S.A.R.) | 3 |
| Singapore | 3 |
| South Africa | 2 |
| United Kingdom | 2 |
| Turkey | 2 |
| Poland | 2 |
| Portugal | 1 |
Where are Research Centres of Albumedix Patents Located?
10 Best Albumedix Patents
US8748380B2 is the most popular patent in the Albumedix portfolio. It has received 28 citations so far from companies like Merrimack Pharmaceuticals, Biogen Ma Inc. and Bioverativ Therapeutics.
Below is the list of 10 most cited patents of Albumedix:
| Publication Number | Citation Count |
| US8748380B2 | 28 |
| US20140315817A1 | 26 |
| US8822417B2 | 24 |
| US20160033523A1 | 18 |
| US20170081389A1 | 11 |
| US9493545B2 | 10 |
| US8258102B2 | 10 |
| US20160075763A1 | 10 |
| US20140315816A1 | 10 |
| US7993877B2 | 9 |
What Percentage of Albumedix US Patent Applications were Granted?
Albumedix (Excluding its subsidiaries) has filed 44 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 25 have been granted leading to a grant rate of 60.98%.
Below are the key stats of Albumedix patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Albumedix?
| Law Firm | Total Applications | Success Rate |
| Knobbe Martens Olson & Bear | 26 | 48.00% |
| Mccarter & English | 13 | 72.73% |
| Novozymes North America | 4 | 100.00% |
| Sughrue Mion | 1 | 100.00% |
What are Albumedix key innovation segments?
What Technologies are Covered by Albumedix?
The chart below distributes patents filed by Albumedix